Peanut Allergy Market Size, Share & Trend Analysis, Epidemiology and Market Forecast 2028

Peanut Allergy Market Size, Share & Trend Analysis, Epidemiology and Market Forecast 2028

Delveinsight Business Research
DelveInsight’s “Peanut Allergy Market Insights, Epidemiology, and Market Forecast 2028” report delivers an in-depth understanding of the Peanut Allergy, historical and forecasted epidemiology as well as the Peanut Allergy Market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

A Peanut Allergy is an allergic reaction to peanuts which occurs when the human body mistakenly identifies peanuts as harmful substances. Peanuts are not the same as tree nuts (almonds, cashews, walnuts, etc.), which grow on trees. In botanical terms, the peanut is not a nut, but a legume. It is one of the types of food that often provoke severe allergic reactions. In some cases, trace amounts of one milligram can trigger a reaction. The allergic components in peanuts are specifically identified proteins. Peanut proteins that activate the immunological response are classified as major or minor allergens.

The Peanut Allergy market report provides in-depth current treatment practices, emerging drugs, Peanut Allergy market share of the individual therapies, current and forecasted Peanut Allergy market Size from 2017 to 2028 segmented by seven major markets. 

The report also provides comprehensive current Peanut Allergy Treatment practice & algorithm, market drivers, market barriers and unmet medical needs to cater best of the opportunities and assessments underlying potential of Peanut Allergy Market.

Peanut Allergy market key facts

  • The National Institute of Allergy and Infectious Disease (NIAID) has reported that approximately one in 90 people in the United States, or 1.1%, have a tree nut and/or peanut allergy and the Food Allergy and Anaphylaxis Network (FAAN) has stated that it is about 0.6% each.

  • As per DelveInsight estimates, the prevalence rate of Peanut Allergy is observed to be higher in children of 0-4 years of age group than children between 5-14 years.

  • Among children, the male prevalence for Peanut Allergy is more than females, which is opposite in the adult population. In adults, the female population is more susceptible to this allergy than males.


Request for Sample Pages: Allergy-market


Key benefits of Peanut Allergy Market report

  • Peanut Allergy market report provides an in-depth analysis of Peanut Allergy market, size, share, trend analysis,  epidemiology, and market forecast till 2028, in 7 major market i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Peanut Allergy market report covers Peanut Allergy’s current treatment practices, emerging drugs, market share of the individual therapies.

  • The Peanut Allergy market report covers the marketed and emerging therapies of Peanut Allergy.

  • The Peanut Allergy market report helps businesses understand the Peanut Allergy Market trends that will shape and drive the Peanut Allergy market in upcoming years.

Peanut Allergy Market

The Peanut Allergy market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Peanut Allergy market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. 

Peanut Allergy Market segment gives a thorough detail of Peanut Allergy Market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. 



Peanut Allergy Epidemiology

The Peanut Allergy Epidemiology division provides insights about historical and current Peanut Allergy patient pool and forecasted trends for every seven major countries. 

The disease epidemiology covered in the report provides historical as well as forecasted Peanut Allergy Epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2028. 

The epidemiology segment also provides the Peanut Allergy epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan along with diagnosed patient pools and their trends with assumptions undertaken.

The launch of the emerging therapies is expected to significantly impact the Peanut Allergy Treatment scenario in the upcoming years. Some of the emerging and marketed drugs covered in the report include RVT‐1401, Teprotumumab, and many others. The key players in the Peanut Allergy market include Immunovant Sciences, Horizon Therapeutics, and many others.


Table of content

1. Key Insights

2. Executive Summary of Peanut Allergy

3. Peanut Allergy Competitive Intelligence Analysis

4. Peanut Allergy Market Overview at a Glance

5. Peanut Allergy Disease Background and Overview

6. Peanut Allergy Patient Journey

7. Peanut Allergy Epidemiology and Patient Population

8. Peanut Allergy Treatment Algorithm, Current Treatment, and Medical Practices

9. Peanut Allergy Unmet Needs

10. Key Endpoints of Peanut Allergy Treatment

11. Peanut Allergy Marketed Products

12. Peanut Allergy Emerging Therapies

13. Peanut Allergy Seven Major Market Analysis

14. Attribute analysis

15. Peanut Allergy Market Outlook (in 7 major markets)

16. Access and Reimbursement Overview of Peanut Allergy

17. KOL Views on the Peanut Allergy market.

18. Peanut Allergy Market Drivers

19. Peanut Allergy Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Related Reports:-

Peanut Allergy Epidemiology Forecast to 2030

DelveInsight’s ‘Peanut Allergy Epidemiology Forecast to 2028’ report delivers an in-depth understanding of the disease, historical and forecasted Peanut Allergy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Peanut Allergy Pipeline Insights, 2020

“Peanut Allergy Pipeline Insight, 2020” report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Peanut Allergy market. A detailed picture of the Peanut Allergy pipeline landscape is provided, which includes the disease overview and Peanut Allergy treatment guidelines.


Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States